LabCorp Counters Correlogic's Motion in Bankruptcy Case to Reject OvaCheck Licensing Agreements

In the objection, LabCorp said that it intends to retain its rights to the test and that even if the licensing agreement is rejected, the company will retain "significant rights" under 365(n) of the Bankruptcy Code.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.